フローサイトメトリーの世界市場：分析装置、選別機、試薬、消耗品、ソフトウェア...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Evolution
3.3 Current Scenario
3.4 Future Outlook
3.5 Conclusion

4 Premium Insights (Page No. – 35)
4.1 Global Market (2016–2021)
4.2 Global Market Share, By Products & Services (2016 vs 2021)
4.3 Market, By Application (2016 vs 2021)
4.4 Global Market Size, By Region (2016-2021)

5 Market Overview (Page No. – 38)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Technology
5.2.2 By Products & Services
5.2.3 By Application
5.2.4 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Technological Advancements in Flow Cytometers
5.3.1.2 Growing Adoption of Flow Cytometry Techniques in Research Activities
5.3.1.3 Increasing Use of Flow Cytometry in Clinical Trials
5.3.1.4 Growing Prevalence of HIV and Cancer
5.3.1.5 Launch of New Reagents for Specific Applications Like Diagnostics and Drug Discovery
5.3.1.6 Development of User-Friendly and Intuitive Software
5.3.2 Restraints
5.3.2.1 High Cost of Instruments
5.3.2.2 Lack of Awareness and Technical Knowledge Regarding the Use of Flow Cytometers
5.3.2.3 Reluctance Among Researchers to Use Flow Cytometer in Emerging Countries
5.3.3 Opportunities
5.3.3.1 Emerging Markets Offer Growth Opportunities
5.3.3.2 Growth in Stem Cell Research
5.3.3.3 Evolution of High-Throughput Flow Cytometry Generations
5.3.4 Challenges
5.3.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.3.4.2 Complexities Related to Reagent Development
5.4 Regulatory Challenges
5.4.1 Challenging Fda Requirements
5.4.2 Stringent Analyte-Specific Reagent (ASR) Rule
5.4.3 Validation Challenges for Cell-Based Instruments
5.4.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays
5.4.5 Changing Regulatory Environment
5.5 Reimbursement Scenario

6 Global Flow Cytometry Market, By Technology (Page No. – 50)
6.1 Introduction
6.2 Cell-Based Flow Cytometry
6.3 Bead-Based Flow Cytometry

7 Global Flow Cytometry Market, By Products & Services (Page No. – 55)
7.1 Introduction
7.1.1 Reagents and Consumables
7.1.2 Flow Cytometry Instruments
7.1.2.1 Cell Analyzers
7.1.2.1.1 Cell Analyzers Market, By Price Range
7.1.2.2 Cell Sorters
7.1.2.2.1 Cell Sorters Market, By Price Range
7.1.3 Services
7.1.4 Software
7.1.5 Accessories

8 Global Flow Cytometry Market, By Application (Page No. – 66)
8.1 Introduction
8.2 Research Applications
8.2.1 Pharmaceutical and Biotechnology
8.2.1.1 Drug Discovery
8.2.1.2 Stem Cell Research
8.2.1.3 in Vitro Toxicity Testing
8.2.2 Immunology
8.2.3 Cell Sorting
8.2.4 Apoptosis
8.2.5 Cell Cycle Analysis
8.2.6 Cell Viability
8.2.7 Others
8.3 Clinical Applications
8.3.1 Cancer
8.3.2 Hematology
8.3.3 Immunodeficiency Diseases
8.3.4 Organ Transplantation
8.3.5 Others
8.4 Industrial Applications

9 Global Flow Cytometry Market, By End User (Page No. – 86)
9.1 Introduction
9.2 Commercial Organizations
9.3 Medical Schools and Academic Institutions
9.4 Hospitals
9.5 Research Institutes
9.6 Clinical Testing Labs

10 Global Flow Cytometry Market, By Region (Page No. – 93)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World

11 Competitive Landscape (Page No. – 128)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches and Product Approval
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Acquisitions
11.3.4 Geographic Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 137)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Becton, Dickinson and Company
12.3 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
12.4 Thermo Fisher Scientific, Inc.
12.5 Merck KGAA
12.6 Bio-Rad Laboratories, Inc.
12.7 Affymetrix, Inc. (A Thermo Fisher Scientific, Inc. Company)
12.8 Miltenyi Biotec GmbH
12.9 Sysmex Partec GmbH (A Subsidiary of Sysmex Corporation)
12.10 Luminex Corporation
12.11 Sony Biotechnology Inc. (A Wholly Owned Subsidiary of Sony Corporation of America)

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 177)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports